Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $660.13 | 26 | 81.5% |
| Consulting Fee | $150.00 | 1 | 18.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $250.00 | 2 | $0 (2024) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $118.16 | 7 | $0 (2019) |
| Allergan Inc. | $60.46 | 2 | $0 (2017) |
| Purdue Pharma L.P. | $55.79 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $48.97 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $36.59 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $24.30 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.97 | 1 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $17.78 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.00 | 2 | Eisai Inc. ($250.00) |
| 2019 | $64.57 | 5 | Janssen Pharmaceuticals, Inc ($26.94) |
| 2018 | $230.91 | 7 | COMSORT, Inc ($150.00) |
| 2017 | $264.65 | 13 | Janssen Pharmaceuticals, Inc ($61.83) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 09/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/31/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: UROLOGY | ||||||
| 08/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2018 | COMSORT, Inc | GARDASIL (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: VACCINE | ||||||
| 08/30/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Neuroscience | ||||||
| 07/26/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Anemia | ||||||
| 06/25/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2018 | Purdue Pharma L.P. | SYMPROIC (Drug) | Food and Beverage | Cash or cash equivalent | $14.75 | General |
| Category: CONSTIPATION | ||||||
| 12/14/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/16/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2017 | Purdue Pharma L.P. | SYMPROIC (Drug), OXYCONTIN | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: CONSTIPATION | ||||||
| 10/26/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/11/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $44.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Opioid Induced Constipation | ||||||
| 07/06/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/18/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: DIABETES | ||||||
| 05/01/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 632 | 2,372 | $240,875 | $153,860 |
| 2022 | 15 | 654 | 2,409 | $224,818 | $144,743 |
| 2021 | 16 | 699 | 2,426 | $224,778 | $144,642 |
| 2020 | 14 | 647 | 2,403 | $210,759 | $129,234 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 54 | 874 | $78,304 | $52,908 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 345 | $38,170 | $22,620 | 59.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 154 | $21,828 | $14,881 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 151 | $23,561 | $14,403 | 61.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 209 | $19,698 | $13,430 | 68.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 47 | 141 | $18,065 | $12,170 | 67.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 38 | $7,785 | $5,322 | 68.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $3,975 | $3,812 | 95.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 23 | 28 | $4,472 | $3,049 | 68.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 18 | 19 | $4,139 | $2,673 | 64.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 93 | 250 | $11,625 | $2,100 | 18.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 56 | $2,520 | $1,902 | 75.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 17 | $2,334 | $1,591 | 68.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 23 | $2,230 | $1,520 | 68.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $2,170 | $1,479 | 68.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 63 | 731 | $60,534 | $40,864 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 377 | $42,335 | $25,956 | 61.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 358 | $30,283 | $20,842 | 68.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 163 | $19,816 | $13,617 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 104 | $16,433 | $10,492 | 63.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 42 | 119 | $12,927 | $8,873 | 68.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 36 | 48 | $7,372 | $5,068 | 68.8% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 63 | 63 | $4,410 | $4,318 | 97.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 37 | $5,937 | $4,081 | 68.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 24 | $5,645 | $3,873 | 68.6% |
About Dr. Frederic Glatter, MD
Dr. Frederic Glatter, MD is a Family Medicine healthcare provider based in Highland Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679551832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederic Glatter, MD has received a total of $810.13 in payments from pharmaceutical and medical device companies, with $250.00 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($660.13).
As a Medicare-enrolled provider, Glatter has provided services to 2,632 Medicare beneficiaries, totaling 9,610 services with total Medicare billing of $572,479. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Highland Park, NJ
- Active Since 01/06/2006
- Last Updated 07/13/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679551832
Products in Payments
- Leqembi (Drug) $250.00
- GARDASIL (Biological) $150.00
- XARELTO (Drug) $103.34
- JANUVIA (Drug) $48.97
- VIBERZI (Drug) $44.10
- SYMPROIC (Drug) $33.99
- ENTRESTO (Drug) $24.30
- Movantik (Drug) $23.93
- JARDIANCE (Drug) $22.97
- OXYCONTIN (Drug) $21.80
- NAMZARIC (Drug) $16.36
- INVOKANA (Drug) $14.82
- MYRBETRIQ (Drug) $13.33
- INJECTAFER (Drug) $12.66
- Trintellix (Drug) $12.53
- MOVANTIK (Drug) $11.78
- Amitiza (Drug) $5.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Highland Park
Dr. Ruth Mays, Md, MD
Family Medicine — Payments: $3,743
Dr. Arthur Miller, Md, MD
Family Medicine — Payments: $1,709
Inna Hoffman, Apn, APN
Family Medicine — Payments: $1,500
Branden Staller
Family Medicine — Payments: $442.61
Dr. Veena Korah, M.d, M.D
Family Medicine — Payments: $421.96
Dr. Sunitha Nambiar, M.d, M.D
Family Medicine — Payments: $212.61